(Q40104724)

17 September 2017

1 reference

title

The biochemistry and pathophysiology of the contact system of plasma (English)

1 reference

17 September 2017

The Biochemistry and Pathophysiology of the Contact System of Plasma (English)

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

22 August 2023

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6182767

22 August 2023

2

J. H. Griffin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6182767

22 August 2023

author name string

C. G. Cochrane

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6182767

22 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6182767

22 August 2023

publication date

1 January 1982

1 reference

17 September 2017

published in

Advances in Immunology

1 reference

17 September 2017

volume

33

1 reference

17 September 2017

page(s)

241-306

1 reference

Plasma kallikrein activity and prekallikrein levels during endotoxin shock in dogs

17 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Hypotension associated with prekallikrein activator (Hageman-factor fragments) in plasma protein fraction

22 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Development of Pain-producing Substance in Human Plasma

22 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Pain-producing substance in human inflammatory exudates and plasma

22 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Immunochemical studies of plasma kallikrein

22 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Vasodilator Effect of Commercial 5% Plasma Protein Fraction Solutions

22 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

THE CLOT-PROMOTING EFFECT OF SOAPS OF LONG-CHAIN SATURATED FATTY ACIDS.

22 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate

22 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Proceedings of the Society for Experimental Biology and Medicine

22 August 2023

21

135

959

Burrowes

1972

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The inhibition of human plasma Kallikrein by antithrombin III

22 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Lowering of kininogen in rat blood by adrenaline and its inhibition by sympatholytic agents, heparin and aspirin

22 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Interaction between factor XII (Hageman factor), high molecular weight kininogen and prekallikrein

22 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The inhibition of activated factor XII (hageman factor) by antithrombin III: The effect of other plasma proteinase inhibitors

22 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Studies on leukokinins. II. Studies on the formation, partial amino acid sequence and chemical properties of leukokinins M and PMN.

22 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Purification and characterization of bovine coagulation factor XII (Hageman factor)

22 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Dissemination of contact activation in plasma by plasma kallikrein

22 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The participation of high molecular weight kininogen in hypotensive shock and intravascular coagulation

22 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).

22 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The Interaction of Hageman Factor and Immune Complexes

22 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein

22 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Activation of plasminogen by human plasma kallikrein

22 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein

22 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways

22 August 2023

39

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Plasma kallikrein activation and inhibition during typhoid fever

22 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Detection of active kallikrein in induced blister fluids of hereditary angioedema patients

22 August 2023

42

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Anticoagulant Action of Heparin

22 August 2023

43

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Inactive renin in human plasma

22 August 2023

47

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Activation of Inactive Plasma Renin by Plasma and Tissue Kallikreins

22 August 2023

49

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Activators of Inactive Renin (‘Prorenin’) in Human Plasma: Their Connection with Kinin Formation, Coagulation and Fibrinolysis

22 August 2023

50

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

An intrinsic factor XII- prekallikrein-dependent pathway activates the human plasma renin-angiotensin system

22 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Hageman factor: alterations in physical properties during activation

22 August 2023

54

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Defective esterase and kinin-forming activity in human Fletcher trait plasma. A fraction rich in kallikreinlike activity

22 August 2023

55

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma

22 August 2023

57

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

British Journal of Pharmacology

22 August 2023

59

22

87

Eisen

1964

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Bovine factor IX (christmas factor). Further evidence of homology with factor X (Stuart factor) and prothrombin

22 August 2023

62

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Rheumatoid factor and kinin generation

22 August 2023

63

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Detection by fluorescence of structural changes accompanying the activation of Hageman factor (factor XII).

22 August 2023

66

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Studies on leukokinins. 3. Pharmacological activities of leukokinins M and PMN.

22 August 2023

69

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Characterization of bovine factor XIIa (activated Hageman factor)

22 August 2023

73

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Isolation and characterization of bovine factor XII (Hageman factor).

22 August 2023

74

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Activation of bovine factor XII (Hageman factor) by plasma kallikrein

22 August 2023

75

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Falls in plasma levels of prekallikrein, high molecular weight kininogen, and kallikrein inhibitors during lethal endotoxin shock in dogs

22 August 2023

77

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The purification of a human plasma kallikrein with weak plasminogen activator activity

22 August 2023

78

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Activation of the classical pathway of complement by Hageman factor fragment

22 August 2023

79

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments

22 August 2023

86

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

PATHOGENESIS OF INFLAMMATION. II. IN VIVO OBSERVATIONS OF THE INFLAMMATORY EFFECTS OF ACTIVATED HAGEMAN FACTOR AND BRADYKININ

22 August 2023

88

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The kinin-forming and kininase activities of rabbit polymorphonuclear leucocytes

22 August 2023

89

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Role of surface in surface-dependent activation of Hageman factor (blood coagulation Factor XII)

22 August 2023

94

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Human factor XII (Hageman factor)

22 August 2023

96

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor

22 August 2023

97

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Recent Advances in The Understanding of Contact Activation Reactions

22 August 2023

98

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Isolation of two functionally different kininogens from human plasma--separation from proteinase inhibitors and interaction with plasma kallikrein

22 August 2023

101

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Inhibitors of kallikrein and other proteinases from animal blood

22 August 2023

102

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

22 August 2023

Journal of Biochemistry

104

77

55

Han

1975

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Primary structure of bovine plasma high-molecular-weight kininogen. The amino acid sequence of a glycopeptide portion (fragment 1) following the C-terminus ot the bradykinin moiety

22 August 2023

105

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Actions of Urinary Kallikrein, Plasmin, and Other Kininogenases on Bovine Plasma High-Molecular-Weight Kininogen1

22 August 2023

106

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The role of Hageman factor in the initiation of blood coagulation

22 August 2023

107

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein

22 August 2023

108

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Separation of Plasma Thromboplastin Antecedent from Kallikrein by the Plasma α2-Macroglobulin, Kallikrein Inhibitor

22 August 2023

109

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Studies on the interaction between collagen and a plasma kallikrein-like activity. Evidence for a surface-active enzyme system

22 August 2023

110

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin

22 August 2023

111

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The Relation of ‘Fletcher Factor’ to Factors XI and XII

22 August 2023

114

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Fletcher Factor Deficiency: A Report of Three Unrelated Cases

22 August 2023

116

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1-antitrypsin

22 August 2023

118

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Isolation and characterization of bovine plasma prekallikrein (Fletcher factor)

22 August 2023

119

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Surface activation of blood coagulation, fibrinolysis and kinin formation

22 August 2023

121

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Kinin system responses in sepsis after trauma in man.

22 August 2023

122

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Hageman factor fragment inhibitor in corn seeds: purification and characterization.

22 August 2023

123

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Plant inhibitors of serine proteinases: Hageman factor fragment, kallikreins, plasmin, thrombin, factor Xa, trypsin, and chymotrypsin

22 August 2023

124

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Enzymatic properties of human Hageman factor fragment with plasma prekallikrein and synthetic substrates

22 August 2023

125

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

British Journal of Pharmacology

22 August 2023

128

29

25

Jacobsen

1967

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

22 August 2023

130

63

219

James

1956

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Mediators of inflammation in leukocyte lysosomes. IX. Elastinolytic activity in granules of human polymorphonuclear leukocytes

22 August 2023

131

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

THE PRESENCE OF TWO PERMEABILITY GLOBULINS IN HUMAN SERUM

22 August 2023

136

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin

22 August 2023

138

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator

22 August 2023

139

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein

22 August 2023

141

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator

22 August 2023

142

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Hageman Factor Activation and Kinin Formation in Human Plasma Induced by Cellulose Sulfate Solutions

22 August 2023

149

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Endotoxin-Induced Kinin Production in Man

22 August 2023

152

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Activation of bovine factor VII (proconvertin) by factor XIIa (activated Hageman factor)

22 August 2023

153

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Quantification of Human High-Molecular-Weight Kininogen (HMW-KGN) by Specific Hemagglutination Inhibition Reaction

22 August 2023

154

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Active site of bovine factor XI (plasma thromboplastin antecedent)

22 August 2023

157

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Isolation and characterization of bovine factor XI (plasma thromboplastin antecedent)

22 August 2023

158

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor)

22 August 2023

162

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Mechanism of activation of bovine factor XI by factor XII and factor XIIa

22 August 2023

163

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Factor XII-induced fibrinolysis: studies on the separation of prekallikrein, plasminogen proactivator, and factor XI in human plasma.

22 August 2023

164

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Cold-promoted activation of factor VII in human plasma: studies on the associated acyl-argin?ne esterase activity

22 August 2023

165

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein

22 August 2023

168

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Assay and Properties of Serum Inhibitor of C'1-Esterase

22 August 2023

169

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Potentiation of the function of Hageman factor fragments by high molecular weight kininogen

22 August 2023

170

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Crystal-induced inflammation in canine joints. I. An experimental model with quantification of the host response

22 August 2023

171

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Inhibitors of kallikrein in human plasma

22 August 2023

172

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The secondary structure of human Hageman factor (factor XII) and its alteration by activating agents

22 August 2023

173

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Relationships Between Platelets and Coagulation Factors in Hemostasis

22 August 2023

175

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma

22 August 2023

178

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Activation of a Permeability Factor in Plasma by Contact with Glass

22 August 2023

180

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Hagerman factor and capillary permeability

22 August 2023

181

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The effect of colloidal silica on blood coagulation

22 August 2023

182

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Activation of Hagemen Factor by saturated fatty acids

22 August 2023

183

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The interrelationship of coagulation of plasma and release of peptides

22 August 2023

184

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Plasma Kallikrein and Hageman Factor in Gram-Negative Bacteremia

22 August 2023

185

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Flaujeac factor deficiency. Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen

22 August 2023

186

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein

22 August 2023

187

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Interaction of Plasma Kinins and Granulocytes

22 August 2023

189

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

STUDIES ON INFLAMMATION : XIV. ISOLATION OF THE FACTOR CONCERNED WITH INCREASED CAPILLARY PERMEABILITY IN INJURY.

22 August 2023

190

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Studies on Human High Molecular Weight (HMW) Kininogen. II. Structural Change of HMW Kininogen by the Action of Human Plasma Kallikrein1

22 August 2023

195

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins).

22 August 2023

196

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Inactivator of the first component of human complement (C1INA). Enhancement of C1INA activity against C1s by acidic mucopolysaccharides

22 August 2023

208

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

22 August 2023

Journal of Biochemistry

209

74

401

Nagasawa

1973

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Studies on human kininogens. I. Isolation, characterization, and cleavage by plasma kallikrein of high molecular weight (HMW)-kininogen

22 August 2023

210

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Release of leukocyte kallikrein mediated by IgE

22 August 2023

211

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Release of leukocyte kallikrein mediated by IgE

22 August 2023

212

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Anaphylactic release of a basophil kallikrein-like activity. I. Purification and characterization

22 August 2023

213

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Anaphylactic relase of a basophil kallikrein-like activity. II. A mediator of immediate hypersensitivity reactions

22 August 2023

214

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Contribution of kinins to endotoxin shock in unanesthetized Rhesus monkeys

22 August 2023

218

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Adsorption of hageman factor (factor XII) on collagen

22 August 2023

220

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Activation of Factors XII (Hageman) and XI (PTA) by Skin Contact

22 August 2023

223

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Inhibition of Hageman factor activation

22 August 2023

224

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors

22 August 2023

227

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Vascular permeability factors (PF/Nat and PF/Dil)—their relationship to hageman factor and the kallikrein-kinin system

22 August 2023

228

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Possible physiological role of new peptide fragments released from bovine high molecular weight kininogen by plasma kallikrein

22 August 2023

229

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Further studies on biological activities of new peptide fragments derived from high molecular weight kininogen: an enhancement of the vascular permeability increase of the fragments by prostaglandin E2.

22 August 2023

230

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Protease as endogenous activator of inactive renin

22 August 2023

233

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

An aminopeptidase of human neutrophil leucocytes — its possible role in enhanced vascular permeability

22 August 2023

235

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies

22 August 2023

241

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

INCREASED VASCULAR PERMEABILITY INDUCED BY HUMAN PLASMIN.

22 August 2023

244

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition

22 August 2023

249

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent

22 August 2023

250

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Amidolytic properties of single-chain activated Hageman factor

22 August 2023

251

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent

22 August 2023

252

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor

22 August 2023

254

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the molecule

22 August 2023

255

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Structural changes accompanying enzymatic activation of human Hageman factor

22 August 2023

256

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen

22 August 2023

257

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma

22 August 2023

258

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Endotoxin, prekallikrein, complement and systemic vascular resistance. Sequential measurements in man.

22 August 2023

260

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Plasma kallikrein-generating activity evoked by rat peritoneal-fluid mast cells following treatment with epinephrine, 8-bromo-cyclic 3′,5′-guanosine monophosphate or compound 4880

22 August 2023

262

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Purification of high molecular weight kininogen and the role of this agent in blood coagulation

22 August 2023

263

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Inhibition of normal clotting and Fletcher factor activity by rabbit anti-kallikrein antiserum.

22 August 2023

266

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin

22 August 2023

268

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Defective Activation of Clotting, Fibrinolytic, and Permeability-Enhancing Systems in Human Fletcher Trait Plasma

22 August 2023

269

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Fitzgerald Trait: Deficiency of a Hitherto Unrecognized Agent, Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins, and the Property of Diluted Plasma Enhancing Vascular Permeability (PF/Dil

22 August 2023

270

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Inhibitory spectrum of alpha 2-plasmin inhibitor

22 August 2023

273

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

22 August 2023

Kallikreins and kinins

276

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Preparation, characterization, and activation of a highly purified factor XI: evidence that a hitherto unrecognized plasma activity participates in the interaction of factors XI and XII

22 August 2023

277

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Partial purification and characterization of contact activation cofactor

22 August 2023

278

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Identity of contact activation cofactor and Fitzgerald factor

22 August 2023

279

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation

22 August 2023

283

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Journal of Clinical Investigation

22 August 2023

284

52

Schreiber

1973

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Carrageenan and Delayed Hypersensitivity II. Activation of Hageman Factor by Carrageenan and Its Possible Significance

22 August 2023

285

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen

22 August 2023

286

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Human urinary kallikrein converts inactive to active renin and is a possible physiological activator of renin

22 August 2023

287

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikrein

22 August 2023

288

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII

22 August 2023

289

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Structure of crystalline -chymotrypsin. II. A preliminary report including a hypothesis for the activation mechanism

22 August 2023

291

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The Kinin System of Human Plasma V. The Probable Derivation of Prekallikrein Activator from Activated Hageman Factor (XIIa)

22 August 2023

294

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Hageman trait and PTA deficiency; the role of contact of blood with glass

22 August 2023

295

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Nuclear division in Escherichia coli as revealed by acid fuchsin

22 August 2023

296

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Functional sites of bovine high molecular weight kininogen as a cofactor in kaolin-mediated activation of factor XII (Hageman factor).

22 August 2023

299

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Inactivation of Acid Proteases from Rhizopus chinensis, Aspergillus saitoi and Mucor pusillus, and Calf Rennin by Diazoacetylnorleucine Methyl Ester*

22 August 2023

300

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Studies on prekallikrein of bovine plasma. II. Activation of prekallikrein with proteinases and properties of kallikrein activated by bovine Hageman factor

22 August 2023

301

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Conversion of Hageman factor (Factor XII) of the guinea pig to prekallikrein activator and inhibition of the formed kallikrein by a natural plasma inhibitor

22 August 2023

302

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Kinetics of activation of prekallikrein by prekallikrein activator

22 August 2023

303

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Association of factor XI and high molecular weight kininogen in human plasma

22 August 2023

305

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Characterization of human high molecular weight kininogen. Procoagulant activity associated with the light chain of kinin-free high molecular weight kininogen

22 August 2023

306

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Bovine factor X1 (Stuart factor): amino-acid sequence of heavey chain

22 August 2023

307

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Rabbit prekallikrein. Purification, biochemical characterization, and mechanism of activation

22 August 2023

308

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Inhibition of purified plasma Kallikrein by antithrombin III and heparin

22 August 2023

310

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Prekallikrein and plasminogen proactivator: Absence of plasminogen proactivator in fletcher factor deficient plasma

22 August 2023

311

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The Role of Platelets in the Contact Phase of Blood Coagulation

22 August 2023

315

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The effects of collagen and kaolin on the intrinsic coagulant activity of platelets. Evidence for an alternative pathway in intrinsic coagulation not requiring factor XII

22 August 2023

316

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Role of Hageman Factor in the Activation of Vasodilator Activity in Human Plasma

22 August 2023

321

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation

22 August 2023

322

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Purification and some properties of a kininogenase from human plasma activated by surface contact

22 August 2023

323

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

The autoactivation of rabbit Hageman factor

22 August 2023

324

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein

22 August 2023

325

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Rabbit blood coagulation factor XI. Purification and properties

22 August 2023

326

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Rabbit blood coagulation factor XI. Mechanism of activation by rabbit Hageman factor (factor XII)

22 August 2023

327

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit

22 August 2023

328

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells

22 August 2023

329

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Aggregation of platelets by collagen

22 August 2023

331

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Prekallikrein deficiency in man

22 August 2023

334

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Plasma prekallikrein: isolation, characterization, and mechanism of activation

22 August 2023

336

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Effect of Plasma Kallikrein on Coagulation in Vitro

22 August 2023

337

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Flaujeac trait. Deficiency of human plasma kininogen

22 August 2023

339

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

A protease-like permeability factor in the guinea pig skin 1. Patial purification and characterization

22 August 2023

341

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Purification of guinea-pig plasma prekallikrein. Activation by prekallikrein activator derived from guinea-pig skin

22 August 2023

342

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

Preparative purification of the rat mast cell chymase. Characterization and Interaction with granule components

22 August 2023

343

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60837-8

22 August 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6182767

22 August 2023

1 reference